Subscribe To
Satsuma pharmaceuticals provides sts101 development program and corporate update
Further analysis of results from recently-completed SUMMIT Phase 3 efficacy trial of sts101 for the acu...
December 20, 2022, 2:21 pm
Further analysis of results from recently-completed SUMMIT Phase 3 efficacy trial of sts101 for the acu...
December 20, 2022, 2:21 pm